Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.

Expanded genetic screening panel for the Ashkenazi Jewish population. Genet Med (2015) 0.77

Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (1999) 5.34

Induction of phenylalanine ammonia-lyase in Xanthium leaf disks. Photosynthetic requirement and effect of daylength. Plant Physiol (1969) 2.45

Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38

Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell (1998) 2.34

Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26

False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost (2009) 2.14

One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood (1995) 2.05

Regulation of pectate lyase synthesis in Pseudomonas fluorescens and Erwinia carotovora. J Bacteriol (1970) 2.05

Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00

Potato phenolases. Purification and properties. J Biol Chem (1965) 1.85

Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71

Characteristics of saccadic gain adaptation in rhesus macaques. J Neurophysiol (1997) 1.70

The pseudomonas hot-foot syndrome. N Engl J Med (2001) 1.65

Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med (1991) 1.56

Low-risk criteria for cervical-spine radiography in blunt trauma: a prospective study. Ann Emerg Med (1992) 1.54

Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (1999) 1.54

Chest teleradiology in a teaching hospital emergency practice. AJR Am J Roentgenol (1997) 1.51

Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. Blood (1991) 1.47

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46

A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states. Am J Clin Pathol (1987) 1.44

Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet (1999) 1.38

Etiologic determinants of abruptio placentae. Obstet Gynecol (1997) 1.35

Inherited thrombophilia: Part 2. Thromb Haemost (1996) 1.34

Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost (1978) 1.30

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood (1991) 1.28

Improved solid medium for the detection and enumeration of pectolytic bacteria. Appl Microbiol (1971) 1.27

Inherited platelet disorders. Haemophilia (2012) 1.27

A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost (1984) 1.17

Turnover and metabolism of chlorogenic Acid in xanthium leaves and potato tubers. Plant Physiol (1966) 1.16

Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood (1995) 1.15

Rate of phenylalanine ammonia-lyase synthesis in darkness. Biochim Biophys Acta (1970) 1.14

Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med (1970) 1.14

Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood (1985) 1.13

Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis (2004) 1.13

Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem (1997) 1.12

The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci U S A (1991) 1.12

Risk factors associated with postpartum ovarian vein thrombosis. Thromb Haemost (1999) 1.11

Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11

Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol (1992) 1.09

Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood (1979) 1.07

The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost (2001) 1.06

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res (1987) 1.06

Changes in Oxidative Enzyme Activity During the Curing of Connecticut Shade Tobacco. Plant Physiol (1958) 1.05

Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds. J Lab Clin Med (1985) 1.04

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest (1979) 1.04

Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. Clin Sci (1971) 1.03

The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood (1997) 1.03

Comparison of hard- and soft-copy digital chest images with different matrix sizes for managing coronary care unit patients. AJR Am J Roentgenol (1995) 1.02

Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res (1992) 1.02

Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood (1989) 1.01

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol (1999) 1.01

Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol (1977) 1.00

Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med (1982) 1.00

Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Thromb Haemost (2000) 0.97

Thrombophilia as a multigenic disorder. Thromb Haemost (1997) 0.97

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. Br Heart J (1990) 0.97

Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost (1987) 0.97

High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood (1978) 0.96

Mendelian diseases among Roman Jews: implications for the origins of disease alleles. J Clin Endocrinol Metab (1999) 0.95

Rare bleeding disorders. Haemophilia (2006) 0.95

Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases. Thromb Diath Haemorrh (1975) 0.95

Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost (2003) 0.94

Primary adenocarcinoma of an anal gland with secondary perianal fistulas. Hum Pathol (1981) 0.94

Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood (1987) 0.94

Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest (1997) 0.94

Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood (1999) 0.94

Thromboembolism in a patient with transient eosinophilia and thrombocytopenia. Clin Lab Haematol (2000) 0.93

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood (1999) 0.93

Prenatal diagnosis of Glanzmann's thrombasthenia. Lancet (1986) 0.93

A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93

Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost (2014) 0.93

Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis (1992) 0.92

Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection. Br J Haematol (1986) 0.92

Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia (2014) 0.92

Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. J Lab Clin Med (1986) 0.92

Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke (2001) 0.91

Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17. Br J Haematol (1998) 0.91

Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol (1994) 0.90

Triggered C-reactive protein (CRP) concentrations and the CRP gene -717A>G polymorphism in acute stroke or transient ischemic attack. Eur J Neurol (2007) 0.90

Induction of Phenylalanine Ammonia-lyase in Strawberry Leaf Disks: Action Spectra and Effects of Wounding, Sucrose, and Light. Plant Physiol (1974) 0.89